FINWIRES · TerminalLIVE
FINWIRES

Wolfe Research Initiates Taysha Gene Therapies at Outperform

By

Taysha Gene Therapies (TSHA) has an average rating of buy and mean price target of $13, according to analysts polled by FactSet.

What else is happening in Research?